XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows From Operating Activities:    
Net Loss $ (16,317) $ (23,733)
Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities:    
Depreciation and Amortization 422 535
Stock-based Compensation 95 558
Increase in Inventory Reserves 307 89
Amortization of Right of Use Asset 1,518 1,312
Amortization of Debt Financing Costs and Accretion of Debt Discount 276 276
(Gain) Loss on Disposal of Assets (3) 7
Realized (Gain) Loss on Sale of Investments Available-for-Sale (4) 1
Foreign Currency Translation Adjustment (3) 3
Changes in Assets and Liabilities:    
Increase in Accounts Receivable, net (1,454) (1,865)
Increase in Inventory (921) (554)
Decrease in Prepaid and Other Assets 2,058 1,760
(Decrease) Increase in Accounts Payable (688) 679
Decrease in Lease Liability (1,435) (1,266)
Increase (Decrease) in Other Liabilities 756 (825)
Decrease in Deferred License Revenue (1,427) (1,485)
Changes in Assets and Liabilities (3,111) (3,556)
Cash Used In Operating Activities (16,820) (24,508)
Cash Flows From Investing Activities:    
Purchase of Investments Available-for-Sale (17,389) (19,107)
Sale of Investments Available-for-Sale 11,972 19,286
Purchase of Equipment (197) (408)
Cash Used In Investing Activities (5,614) (229)
Cash Flows From Financing Activities:    
Payments on Debt (6,750) 0
Payments on Short Term Note Payable (941) (656)
Proceeds from the Issuance of Common Stock 15,016 0
Offering Costs from the Issuance of Common Stock (106) 0
Proceeds from the Issuance of Preferred Stock 15,000 0
Offering Costs from the Issuance of Preferred Stock (85) 0
Proceeds from the Issuance of Common Stock for payment related to services provided 0 107
Repurchase of Common Stock to Pay Employee Withholding Taxes 0 (6)
Cash Provided by (Used In) Financing Activities 22,134 (555)
Decrease in Cash and Cash Equivalents (300) (25,292)
Cash and Cash Equivalents at Beginning of Period 13,280 48,682
Cash and Cash Equivalents at End of Period 12,980 23,390
Supplemental Disclosure of Cash Flow Information:    
Cash Paid for Interest 1,261 1,318
Supplemental Disclosure of Noncash Investing and Financing Activities:    
Change in Unrealized Loss on Marketable Securities Available-for-Sale $ 5 $ (4)